Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rasmussen

Showing results (361-370 of 364) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 364 results.
Journal of Medicinal Chemistry|June 4, 1999
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivativesL Jeppesen, P H Olesen, L Hansen, et al.
Journal of Gastrointestinal Cancer|November 21, 2015
Downregulated Expression of E-cadherin and TP53 in Patients with Gastric Diseases: the Involvement of H. pylori Infection and Its Virulence MarkersMariane Avante Ferraz, Luanna Munhoz Zabaglia, Weendelly Nayara Pereira, et al.
ACR Open Rheumatology|August 28, 2019
Reproducibility of Ocular Surface Staining in the Assessment of Sjögren Syndrome-Related Keratoconjunctivitis Sicca: Implications on Disease ClassificationAstrid Rasmussen, Donald U Stone, C Erick Kaufman, et al.
BMC Pregnancy and Childbirth|February 21, 2020
Study protocol to investigate biomolecular muscle profile as predictors of long-term urinary incontinence in women with gestational diabetes mellitusMarilza V C Rudge, Fátima P Souza, Joelcio F Abbade, et al.
Pageof 37

Showing results (361-370 of 364) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 364 results.
Journal of Medicinal Chemistry|June 4, 1999
1-(1,2,5-Thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M1 agonists: structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivativesL Jeppesen, P H Olesen, L Hansen, et al.
Journal of Gastrointestinal Cancer|November 21, 2015
Downregulated Expression of E-cadherin and TP53 in Patients with Gastric Diseases: the Involvement of H. pylori Infection and Its Virulence MarkersMariane Avante Ferraz, Luanna Munhoz Zabaglia, Weendelly Nayara Pereira, et al.
ACR Open Rheumatology|August 28, 2019
Reproducibility of Ocular Surface Staining in the Assessment of Sjögren Syndrome-Related Keratoconjunctivitis Sicca: Implications on Disease ClassificationAstrid Rasmussen, Donald U Stone, C Erick Kaufman, et al.
BMC Pregnancy and Childbirth|February 21, 2020
Study protocol to investigate biomolecular muscle profile as predictors of long-term urinary incontinence in women with gestational diabetes mellitusMarilza V C Rudge, Fátima P Souza, Joelcio F Abbade, et al.
Pageof 37